Dobutamine 51662-1330-01
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 7, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA020201
Need to source Dobutamine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dobutamine Hydrochloride | 200 mg/100mL |
Drug Class
Adrenergic beta-Agonists [MoA]beta-Adrenergic Agonist [EPC]
Selected Package
51662-1330-01Selected250 mL in 1 BAG (51662-1330-1)